Literature DB >> 12777097

The early effects of Clostridium perfringens type D epsilon toxin in ligated intestinal loops of goats and sheep.

M E Fernandez Miyakawa1, F A Uzal.   

Abstract

Clostridium perfringens type D produces enterotoxaemia in goats, sheep and other animals. The disease is caused by C. perfringens epsilon toxin and, while enterotoxaemia in goats is usually characterized by enterocolitis, the disease in sheep is characterized by systemic lesions (such as lung and brain oedema) with minor and inconsistent changes observed in the intestine. A possible explanation for these differences is that epsilon toxin is more promptly absorbed by the ovine than by the caprine intestine. In an attempt to clarify this, we examined the early effects of epsilon toxin on caprine and ovine intestine. Intestinal loop assays were performed to analyse the physiological and morphological changes induced by epsilon toxin in the intestine of these species. Fluid accumulation was observed in caprine and ovine ileum and colon treated with epsilon toxin. Ileal loops from goats treated with epsilon toxin retained sodium and water earlier than ovine ileal loops treated with the same toxin. Histological analysis showed morphological alterations in the colon of both species as early as 2 h after the commencement of epsilon toxin treatment: these changes were more marked in goats than in sheep. No morphological changes were observed in the ileum of either species after 4 h incubation with epsilon toxin. These results suggest that epsilon toxin modifies ion and water transport in the small and the large intestine of goats and sheep through different mechanisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12777097     DOI: 10.1023/a:1023348708599

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  12 in total

Review 1.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

2.  Caprine enterotoxaemia associated with cerebral microangiopathy.

Authors:  F A Uzal; J R Glastonbury; W R Kelly; R Thomas
Journal:  Vet Rec       Date:  1997-08-30       Impact factor: 2.695

3.  The prevention of enterotoxaemia (pulpy kidney disease) by vaccination.

Authors:  B C Jansen
Journal:  Bull Off Int Epizoot       Date:  1967 Nov-Dec

4.  Electrolyte transport in rabbit ileum.

Authors:  H J Binder; D W Powell; Y H Tai; P F Curran
Journal:  Am J Physiol       Date:  1973-10

5.  Detection of Clostridium perfringens type D epsilon antitoxin in serum of goats by competitive and indirect ELISA.

Authors:  F A Uzal; K Nielsen; W R Kelly
Journal:  Vet Microbiol       Date:  1997-09       Impact factor: 3.293

6.  Experimental Clostridium perfringens type D enterotoxemia in goats.

Authors:  F A Uzal; W R Kelly
Journal:  Vet Pathol       Date:  1998-03       Impact factor: 2.221

7.  Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex.

Authors:  L Petit; M Gibert; D Gillet; C Laurent-Winter; P Boquet; M R Popoff
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

8.  Effects of the intravenous administration of Clostridium perfringens type D epsilon toxin on young goats and lambs.

Authors:  F A Uzal; W R Kelly
Journal:  J Comp Pathol       Date:  1997-01       Impact factor: 1.311

9.  Differences in signs and lesions in sheep and goats with enterotoxemia induced by intraduodenal infusion of Clostridium perfringens type D.

Authors:  T E Blackwell; D G Butler; J F Prescott; B P Wilcock
Journal:  Am J Vet Res       Date:  1991-07       Impact factor: 1.156

10.  In Vivo Effects of Clostridium perfringens Enteropathogenic Factors on the Rat Ileum.

Authors:  J L McDonel
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

View more
  9 in total

1.  Both epsilon-toxin and beta-toxin are important for the lethal properties of Clostridium perfringens type B isolates in the mouse intravenous injection model.

Authors:  Mariano E Fernandez-Miyakawa; Derek J Fisher; Rachael Poon; Sameera Sayeed; Vicki Adams; Julian I Rood; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2007-01-08       Impact factor: 3.441

2.  Lethal effects of Clostridium perfringens epsilon toxin are potentiated by alpha and perfringolysin-O toxins in a mouse model.

Authors:  Mariano E Fernandez-Miyakawa; B Helen Jost; Stephen J Billington; Francisco A Uzal
Journal:  Vet Microbiol       Date:  2007-10-02       Impact factor: 3.293

3.  Epsilon toxin is essential for the virulence of Clostridium perfringens type D infection in sheep, goats, and mice.

Authors:  J P Garcia; V Adams; J Beingesser; M L Hughes; R Poon; D Lyras; A Hill; B A McClane; J I Rood; F A Uzal
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

4.  Sialidases affect the host cell adherence and epsilon toxin-induced cytotoxicity of Clostridium perfringens type D strain CN3718.

Authors:  Jihong Li; Sameera Sayeed; Susan Robertson; Jianming Chen; Bruce A McClane
Journal:  PLoS Pathog       Date:  2011-12-08       Impact factor: 6.823

5.  The Myelin and Lymphocyte Protein MAL Is Required for Binding and Activity of Clostridium perfringens ε-Toxin.

Authors:  Kareem Rashid Rumah; Yinghua Ma; Jennifer R Linden; Myat Lin Oo; Josef Anrather; Nicole Schaeren-Wiemers; Miguel A Alonso; Vincent A Fischetti; Mark S McClain; Timothy Vartanian
Journal:  PLoS Pathog       Date:  2015-05-20       Impact factor: 6.823

6.  Clostridium perfringens epsilon toxin induces blood brain barrier permeability via caveolae-dependent transcytosis and requires expression of MAL.

Authors:  Jennifer R Linden; Claudia Flores; Eric F Schmidt; Francisco A Uzal; Adam O Michel; Marissa Valenzuela; Sebastian Dobrow; Timothy Vartanian
Journal:  PLoS Pathog       Date:  2019-11-08       Impact factor: 6.823

7.  Clostridium perfringens epsilon toxin increases the small intestinal permeability in mice and rats.

Authors:  Jorge Goldstein; Winston E Morris; César Fabián Loidl; Carla Tironi-Farinati; Carla Tironi-Farinatti; Bruce A McClane; Francisco A Uzal; Mariano E Fernandez Miyakawa
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

8.  Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease.

Authors:  Kareem Rashid Rumah; Jennifer Linden; Vincent A Fischetti; Timothy Vartanian
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

Review 9.  Clostridium perfringens epsilon toxin: a malevolent molecule for animals and man?

Authors:  Bradley G Stiles; Gillian Barth; Holger Barth; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2013-11-12       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.